RECENTIN
Dead / Cancelled — Cancelled — Section 8 (as of 15 Jan 2016)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77532598
- Registration number
- 3634204
- Mark type
- Stylized text
- Filed
- 28 Jul 2008
- Published for opposition
- 24 Mar 2009
- Registered
- 09 Jun 2009
- Attorney of record
- Wm. Charles Saunders
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of cancer
Owner
- IPR PHARMACEUTICALS INC., CAROLINA, PR, US
- AstraZeneca UK Limited, London, GB
- AstraZeneca UK Limited, London, GB
- AstraZeneca UK Limited, London, GB
Prior registrations
Prosecution history
- 15 Jan 2016 — CANCELLED SEC. 8 (6-YR)
- 31 Dec 2009 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Jun 2009 — REGISTERED-PRINCIPAL REGISTER
- 24 Mar 2009 — PUBLISHED FOR OPPOSITION
- 04 Mar 2009 — NOTICE OF PUBLICATION
- 14 Feb 2009 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 13 Feb 2009 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Feb 2009 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Feb 2009 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Feb 2009 — ASSIGNED TO LIE
- 11 Feb 2009 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Sept 2008 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Sept 2008 — NON-FINAL ACTION E-MAILED
- 01 Sept 2008 — NON-FINAL ACTION WRITTEN
- 01 Sept 2008 — ASSIGNED TO EXAMINER